Canton Hathaway’s Zimmer Biomet ZBH Stock Holding History

Canton Hathaway’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-35	Closed	-$5K	–	327
2021 Q1	$5K	Buy	+35	New	+$5.42K	﹤0.01%	297

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Canton Hathaway's ZBH Position: Q2 2021 in Review

Canton Hathaway sold out of Zimmer Biomet (ZBH) in Q2 2021, closing a stake of 35 shares — an estimated $5K sold.

Canton Hathaway first reported a position in ZBH in Q1 2021 and held it in 1 quarter. The position peaked at $5K in Q1 2021. 1,018 funds tracked by Wall St. Rank hold ZBH as of Q2 2021.

Canton Hathaway reported no remaining Zimmer Biomet position as of Q2 2021 after selling out during the quarter.
Canton Hathaway sold 35 Zimmer Biomet shares in Q2 2021, an estimated $5K.
Canton Hathaway first reported a position in Zimmer Biomet in Q1 2021 and held it in 1 quarter.
Canton Hathaway's Zimmer Biomet position peaked at $5K in Q1 2021.
1,018 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2021.

Based on Canton Hathaway's 13F filing for Q2 2021, filed 8 Jul 2021.